HIV medication adherence and HIV symptom severity: The roles of sleep quality and memory

AIDS Patient Care and STDs

Volumn 27, Issue 10, 2013, Pages 544-552

  Babson, Kimberly A ^a,b   Heinz, Adrienne J ^a,b   Bonn Miller, Marcel O ^a,c,d  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ALCOHOL CONSUMPTION; ANTIVIRAL THERAPY; ARTICLE; CANNABIS ADDICTION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MEMORY; MOOD DISORDER; PATIENT COMPLIANCE; PILL; QUESTIONNAIRE; SLEEP QUALITY; TOBACCO DEPENDENCE; ADDICTION; AGED; COGNITION DISORDERS; CROSS-SECTIONAL STUDY; HIV INFECTIONS; MIDDLE AGED; PSYCHOLOGY; QUALITY OF LIFE; SELF REPORT; SEVERITY OF ILLNESS INDEX; SLEEP; SOCIOECONOMICS; UNITED STATES; VIROLOGY; YOUNG ADULT;

ADULT; AGED; ANTI-HIV AGENTS; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; MEMORY; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; SAN FRANCISCO; SELF REPORT; SEVERITY OF ILLNESS INDEX; SLEEP; SOCIOECONOMIC FACTORS; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84885225091     PISSN: 10872914     EISSN: 15577449     Source Type: Journal    
DOI: 10.1089/apc.2013.0221     Document Type: Article

References (59)

1. Montaner J, Lima V, Barrios R, et al. Expanded HAART coverage is associated with decreased population-level HIV-1-RNA and annual new HIV diagnoses in British Columbia, Canada. Lancet 2010;376:532-539.
2. Buchacz K, Baker R, Moorman A, et al. Rates of hospitalizations and associated diagnoses in a large multisite cohort of HIV patients in the United States, 1994-2005. AIDS 2008;22:1345-1354.
3. Crum N, Riffenburgh R, Wegner S, et al. Comparisons of causes of death and mortaility rates among HIV-infected persons. Analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. J Acquir Immune Defic Syndr 2006;41:194-200.
4. The Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: A collaborative analysis of 14 cohort studies. Lancet 2008;372:293-299.
5. Rodger A, Lodwick R, Schechter M, et al. Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population. AIDS 2013;27:973-979.
6. Gross R, Yip B, Lo Re V, et al. A simple, dynamic measure of antiretroviral therapy adherence failure to maintain HIV-I suppression. J Infect Dis 2006;194:1108-1114. (Pubitemid 44547650)
7. Lima V, Harrigan, R, Bangsberg D. et al. The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time. J Acquir Immune Defic Syndr 2009;50:529-536.
8. Amico KR, Simoni JM, Pantalone DW. Enhancing antiretroviral adherence: A 2012 update. In Trafton JA, Gordon W, editors. Best Practices in the Behavioral Management of Chronic Disease, Volume 2: Other Medical Disorders. Los Altos, Ca; Institute for Brain Potential, 2012.
9. Reid S, Dwyer J. Insomnia in HIV infection: A systematic review of prevalence, correlates, and management. Psychosom Res 2005;67:260-269. (Pubitemid 40410962)
10. Rubinstein M, Selwyn P. High prevalence of insomnia in an outpatient population with HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol 1998;19:260-265.
11. Hudson A, Portillo C, Lee K. Sleep disturbances in women with HIV or AIDS. Nurs Res 2008;57:360-366.
12. Wheatley D, Smith K. Clinical sleep patterns in human immune virus infection. Psychopharmacology 1994;9:111-115. (Pubitemid 24133933)
13. Gay C, Portillo C, Kelly et al. Self-reported medication adherence and symptom experience in adults with HIV. J Assoc Nurses AIDS Care 2011;22:257-268.
14. Phillips K, Sowell R, Boyd M, Dudgeon W, Hand G, The Mind-Body Research Group. Sleep quality and healthrelated quality of life in HIV-infected African-American women of childbearing age. Qual Life Res 2005;14:959-970. (Pubitemid 40685220)
15. Saberi P, Neilands T, Johnson M. Quality of sleep: Associations with antiretroviral nonadherence. AIDS Patient Care STDs 2011;25:517-524.
16. Phillips K, Sowell R, Rojas M, Tavakoli A, Fulk L, Hand G. Physiological and psychological correlates of fatigue in HIV disease. Biol Res Nurs 2004;6:59-74. (Pubitemid 44005155)
17. Robbins J, Phillips K, Dudgeon W, Hand G. Physiological and psychological correlates of sleep in HIV infection. Clin Nurs Res 2004;13:33-52. (Pubitemid 38543406)
18. Cruess D, Antoni M, Gonzalez J et al. Sleep disturbance mediates the association between psychological distress and immune status among HIV-positive men and women on combination antiretroviral therapy. J Psychosom Res 2003;54:185-189. (Pubitemid 36388855)
19. Schouten J, Cinque P, Gisslen M, Reiss P, Portegies P. HIV-1 infection and cognitive impairment in the cART era: A review. AIDS 2011;25:561-575.
20. Waters F, Bucks R. Neuopsychological effects of sleep loss: Implications for neuropsychologists. J Int Neuropsychol Soc 2011;17:571-586.
21. Woods S, Moore D, Weber E, Grant I. Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol Rev 2009;19:152-168.
22. Pilcher J, Huffcutt A. Effects of sleep deprivation on performance: A meta-analysis. Sleep 1996;19:318-326. (Pubitemid 26157501)
23. Maki P, Cohen M, Weber K, et al. Impairments in memory and hippocampal function in HIV-positive vs HIV-negative women: A preliminary study. Neurology 2009;72:1661-1668.
24. Carter SL, Rourke SB, Murji S, Shore D, Rourke BP. Cognitive complaints, depression, medical symptoms, and their association with neuropsychological functioning in HIV infection: A structural equation model analysis. Neuropsychol 2003;17:410-419. (Pubitemid 37013152)
25. Lenderking WR, Testa MA, Katzenstein D, Hammer S. Measuring quality of life in early HIV disease: The modular approach. Qual Life Res 1997;6:515-530. (Pubitemid 27431707)
26. Woods SP, Moran LM, Carey CL, Dawson MS, Iudicello JE, et al. Prospective memory in HIV infection: Is remembering to remember a unique predictor of self-reported medication management? Arch Clin Neuropsychol 2008;23:257-270.
27. Woods SP, Iudicello JE, Moran LM, Carey CL, Dawson MS, Grant I. HIV-associated prospective memory impairment increases risk of dependence in everyday functioning. Neuropsychology 2008;22:110-117. (Pubitemid 351241124)
28. Bonolo P, Machadom C, Cesar C, Ceccato M., Guimaraes M. Vulnerability and non-adherence to antiretroviral therapy among HIV patients, Minas Gerair Stet, Brazil. Cadernos saude Publica 2008;24:2603-2613.
29. Cook R, Sereika S, Hunt S, Woodward W, Erlen J, Conigliaro J. Problem drinking and medication adherence among persons with HIV infection. J Gen Intern Med 2001;16:83-88. (Pubitemid 32183566)
30. Pol S, Artru P, Thepot V, Berhelot O, Nalpas B. Improvement of the CD4 cell count after alcohol withdrawal in HIVpositive alcoholic patients. AIDS 1996;10:1293-1294. (Pubitemid 26306612)
31. Webb M, Vanable P, Carey M, Blair D. Cigarette smoking among HIV + men and women: Examining health, substance use, and psychosocial correlates across the smoking spectrum. J Behav Med 2007;30:371-383. (Pubitemid 47206603)
32. Boarts J, Sledjeski E, Bogart L, Delahanty D. The differential impact of PTSD and depression on HIV disease markers and adherence to HAART in people living with HIV. AIDS Behav 2006;10:253-261.
33. Bottonari K, Tripathi S, Fortney J, et al. Correlates of antiretroviral and antidepressant adherence among depressedHIVinfected patients. AIDS Patient Care STDs 2012;26:265-273.
34. Sachs-Ericsson N, Joiner T, Blazer D. The influence of lifetime depression on self-reported memory and cognitive problems: Results from the National Comorbidity Survey-Replication. Aging Mental Health 2008;12:183-192. (Pubitemid 351499609)
35. Staner L. Comorbidity of insomnia and depression. Sleep Med Rev 2010;14:35-46.
36. Tedaldi E, van den Berg-Wolf M, Richardson J, et al. Sadness in the SUN: Using computerized screening to analyze correlates of depression and adherence in HIV-infected adults in the United States. AIDS Patient Care STDs 2012;26:718-729.
37. Thames A, Moizel J, Panos S, et al. Differential predictors of medication adherence in HIV: Findings from a sample of African American and Caucasian HIV-positive drug-using adults. AIDS Patient Care STDs 2012;26:621-630.
38. Bonn-Miller M, Oser M, Bucossi M, Trafton J. Cannabis use and HIV antiviral therapy adherence and HIV-related symptoms. J Behav Med 2012; epub ahead of print. doi: 10.1007/s10865-012-9458-5.
39. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353:487-497. (Pubitemid 41127293)
40. Paterson D, Swindells S, Mohr J et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000;133:21-30. (Pubitemid 30432540)
41. Bangsberg D, Hecht F, Clague H, et al. Provider assessment of adherence to HIV antiretroviral therapy. JAIDS 2001; 26:435-442. (Pubitemid 32489021)
42. Chesney M, Ickovics J, Chambers et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. AIDS Care 2000;12:255-266. (Pubitemid 30426745)
43. Ammassari A, Murri R, Pezzotti P, et al. Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. J Acquir Immune Defic Syndr 2001;28:445-449. (Pubitemid 34033195)
44. Buysse D, Reynolds C, Monk T, Berman S. The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193-213. (Pubitemid 19144991)
45. Babson K, Badour C, Feldner M, Bown, S. Anxiety sensitivity is associated with frequency of sleep medication use above and beyond self-reported sleep quality. Cog Ther Res 2012;36:585-591.
46. Milross M, Piper A, Norman M, Dobbin C, Grunstein R, Sullivan C, Bye P. Subjective sleep quality in cystic fibrosis. Sleep Med 2002;3:205-212. (Pubitemid 34679356)
47. Cornish I. Factor structure of the Everyday Memory Questionnaire. Br J Psycho 2007;91:427-438.
48. Sunderland A, Harris J, Baddeley A. Do laboratory tests predict everyday memory? A neuropsychological study. J Verbal Learning Verbal Behav 1983;22:341-357.
49. Saunders J, Aasland O, Babor T, Fuente J, Grant M. Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption II. Addiction 1993;88:791-804. (Pubitemid 23194530)
50. Heatherton T, Kozlowski L, Frecker R, Fagerström K. The Fagerström Test for Nicotine Dependence: A revision of the Fagerström Tolerance Questionnaire. Br J Addict 1991; 86:1119-1127.
51. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV (SCID-I) (User's Guide and Interview) Research Version. New York, NY: Biometrics Research Department, New York Psychiatric Institute; 1995.
52. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: Conceptual, strategic and statistical considerations. J Pers Soc Psychol 1986;51:1173-1182.
53. Sobel ME. Direct and indirect effect in linear structural equation models. In Long JS, ed, Common Problems/Proper Solutions: Avoiding Error in Quantitative Research. Beverly Hills, CA: Sage; 1988, pp. 46-64.
54. Aiken L, West S. Multiple Regression: Testing and Interpreting Interactions. Newbury Park, CA: Sage, 1991.
55. Hayes A. SPSS MODMED Macro Syntax. http://www .afhayes.com/public/modmed. pdf; 2011.
56. French T, Tesoriero J, Agins B. Change in stress, substance use and medication beliefs are associated with changes in adherence to HIV antiretroviral therapy. AIDS Behav 2011;15:1416-1428.
57. Friedman M, Marchal M, Stall R, et al. Associations between substance use, sexual risk taking and HIV treatment adherence among homeless people living with HIV. AIDS Care 2009;21:692-700.
58. Preacher K, Rucker D, Hayes A. Addressing moderated mediation hypotheses: Theory, methods, and prescriptions. Multivariate Behav Res 2007;42:185-127.
59. Kenny D, Kashy D, Bolger N. Data analysis in social psychology. In: Gilbert DT, Fiske ST, Lindzey G, eds. The Handbook of Social Psychology: 4th ed. New York: McGraw-Hill, 1998, pp. 233-265.